Iasis Molecular Sciences Inc.
Spokane, WA Doing business as Iasis Molecular Sciences
- UEI
- P8KSLPQ236L5
- CAGE
- 4PJU4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 120 N Pine St, Spokane, WA 99202, USA
- Website
- iasismolecular.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Clinical ecosystem surfaces for improved disinfection outcomes and the prevention of HAI transmission | Office of Financial Resources | $3,905,682 | |
| Preclinical investigations of a novel antimicrobial urinary catheter for improving genitourinary dysfunction | Defense Health Agency | $1,520,348 | |
| Development of supraguard ETT, a next generation composite endotracheal tube for the prevention of ventilator-associated… | National Heart Lung and Blood Institute | $900,540 | |
| Fast? Complementary disinfection for the healthcare environment | Office of Financial Resources | $225,000 | |
| A novel urinary catheter with tailorable bactericidal behavior | Medical Command | $1,031,275 |
About Iasis Molecular Sciences Inc.
Iasis Molecular Sciences Inc. is a for-profit corporate entity registered in SAM.gov since 2007, specializing in the development of advanced medical technologies and antimicrobial devices based in Spokane, Washington. The company focuses on creating innovative medical solutions that address critical healthcare challenges, particularly in infection prevention and medical device technology. As a manufacturer of goods, Iasis Molecular Sciences has established itself as a research-driven organization that develops cutting-edge medical products designed to improve patient outcomes and reduce healthcare-associated infections.
The company has secured multiple federal grant awards from agencies including the Centers for Disease Control and Prevention (CDC), Department of the Army Medical Command, and the National Heart Lung and Blood Institute, totaling approximately $2.89 million in recent grant funding. These grants have supported the development of sophisticated medical technologies such as an antimicrobial urinary catheter to prevent catheter-associated urinary tract infections, a next-generation endotracheal tube (SupraGuard ETT) designed to reduce ventilator-associated pneumonia, and clinical ecosystem surfaces to improve disinfection outcomes. Each project demonstrates Iasis Molecular Sciences' commitment to addressing complex medical challenges through innovative antimicrobial technologies, with a particular emphasis on preventing healthcare-associated infections in clinical and military medical settings. The research grants span preclinical investigations, product development, and technical improvements in medical device design, showcasing the company's multifaceted approach to medical innovation.
Quick answers
What is Iasis Molecular Sciences Inc.'s UEI?
Iasis Molecular Sciences Inc.'s Unique Entity ID (UEI) in SAM.gov is P8KSLPQ236L5.
What is Iasis Molecular Sciences Inc.'s CAGE code?
Iasis Molecular Sciences Inc.'s CAGE code is 4PJU4.
What is Iasis Molecular Sciences Inc.'s primary NAICS code?
Iasis Molecular Sciences Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Iasis Molecular Sciences Inc. located?
Iasis Molecular Sciences Inc.'s physical address in SAM.gov is 120 N Pine St, Spokane, WA 99202, USA.
Is Iasis Molecular Sciences Inc. registered in SAM.gov?
Yes. Iasis Molecular Sciences Inc.'s SAM.gov registration is active through August 21, 2027.
What is Iasis Molecular Sciences Inc.'s most recent federal award?
Iasis Molecular Sciences Inc.'s most recent federal grant award is Clinical ecosystem surfaces for improved disinfection outcomes and the prevention of HAI transmission (R44CK000621), from Office of Financial Resources, on September 30, 2024.
On GovTribe
See Iasis Molecular Sciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors